AUSTIN, Texas — A team of scientists led by chemists Stephen Martin and James Sahn at The University of Texas at Austin have discovered what they say is a powerful pain reliever that acts on a previously unknown pain pathway. … Continue reading →
A study by UA researchers revealed that rats with neuropathic pain that were bathed in green LED showed more tolerance for thermal and tactile stimulus. A clinical trial involving people suffering from fibromyalgia is underway.
Screening more than 100 spider toxins, Yale researchers identified a protein from the venom of the Peruvian green velvet tarantula that blunts activity in pain-transmitting neurons. The findings, reported in the March 3 issue of the journal Current Biology, show … Continue reading →
Successfully treating and reversing the effects of multiple sclerosis, or MS, may one day be possible using a drug originally developed to treat chronic pain, according to Distinguished Professor Linda Watkins of the University of Colorado at Boulder. Watkins and … Continue reading →